Enhancing the regeneration of cartilage defects remains challenging owing to limited innate self-healing as well as acute
inflammation arising from the overexpression of
reactive oxygen species (ROS) in post-traumatic microenvironments. Recently, stem cell-derived exosomes (Exos) have been developed as potential cell-free
therapy for cartilage regeneration. Although this approach promotes chondrogenesis, it neglects the emerging inflammatory microenvironment. In this study, a smart bilayer-
hydrogel dual-loaded with
sodium diclofenac (DC), an anti-inflammatory drug, and Exos from bone marrow-derived mesenchymal stem cells was developed to mitigate initial-stage
inflammation and promote late-stage stem-cell recruitment and chondrogenic differentiation. First, the upper-
hydrogel composed of
phenylboronic-acid-crosslinked
polyvinyl alcohol degrades in response to elevated levels of ROS to release DC, which mitigates oxidative stress, thus reprogramming macrophages to the pro-healing state. Subsequently, Exos are slowly released from the lower-
hydrogel composed of
hyaluronic acid into an optimal microenvironment for the stimulation of chondrogenesis. Both in vitro and in vivo assays confirmed that the dual-loaded bilayer-
hydrogel reduced post-traumatic
inflammation and enhanced cartilage regeneration by effectively scavenging ROS and reprogramming macrophages. The proposed platform provides multi-staged
therapy, which allows for the optimal harnessing of Exos as a therapeutic for cartilage regeneration.